BI Trial
Laufzeit: 01.01.2013 - 31.12.2014
imported
Kurzfassung
BIBF added to standard Gemcitabine/Cisplatin therapy in first line NSCLC with squamous cell histology
Laufzeit: 01.01.2013 - 31.12.2014
BIBF added to standard Gemcitabine/Cisplatin therapy in first line NSCLC with squamous cell histology